SLC7A11 expression significantly correlated with both pathological tumor (pT) stage and tumor grade (Figure 6B,C), showing a significant increase in low pT stages (pT1-pT2) as well as low tumor grades (G1–G2) with further enhancement in higher pT stages (pT3-pT4) as well as higher tumor grades (G3–G4) compared to healthy adjacent control tissue from the same patient. The gene discussed is SLC7A11; the disease is neoplasm.